Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children

Update Il y a 4 ans
Reference: NCT01195779

Woman and Man

  • | Country :
  • Spain
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this observer-blind study is to evaluate the safety and immunogenicity of GlaxoSmithKline Biologicals' influenza vaccine GSK2584786A in healthy children 6 to 35 months of age.


Inclusion criteria

  • Influenza

Links